Adaptimmune Limited
3711 Market St Ste 800
Philadelphia, PA 19104
Adaptimmune is a Philadelphia-based company that is revolutionizing the treatment of solid tumor cancers. They are committed to using a personalized cell therapy platform that harnesses a patient's own cells to combat their cancer, aiming to improve the patient experience and reshape cancer care with a single infusion.
As a fully integrated company on the verge of a new era, Adaptimmune has submitted their first Biologics License Application (BLA) to the FDA and is focused on commercializing the first engineered T-cell therapy in solid tumors, with the goal of improving cancer treatment.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
